Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 7 recent reports on gastrointestinal cancer
2 Immunotherapy is beneficial in gastric and oesophageal cancers, studies show
3 Chi-Med Highlights Clinical Data to be Presented at the Upcoming ESMO Virtual Congress 2020
4 ESMO 2020: Checkpoint blockers move up, and down, the line for gastric tumors
5 Esteemed Peer Perspective Board helps chart course for Healio's Women in Oncology
6 Pembrolizumab appears promising for certain patients with gastric, gastroesophageal cancer
7 Merck's (MRK) KEYTRUDA Plus Chemo Reduced Risk of Death by 27% Versus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Esophageal Cancer
8 Fox Chase Cancer Center announces faculty appointments
9 Chi-Med Highlights Surufatinib Phase III Results in Neuroendocrine Tumors at ESMO 2020 and Publications in The Lancet Oncology
10 Dr. Morris on the Role of Circulating Tumor DNA in Resected Colon Cancer
11 RBG battled five bouts of cancer over two decades
12 Scott Kopetz, MD, PhD, FACP, Discusses Next Steps for GI Oncology
13 Blood test detects common cancer types 4 years before current screening methods
14 Doctors Debate: Should Perioperative Treatment of GEJ/Gastric Cancer Include Radiotherapy?
15 Form 6-K Hutchison China MediTech For: Sep 21
16 Survival Improved With HAIC Over Standard TACE in Unresectable HCC
17 Dr. O'Malley on the Safety Profile of Mirvetuximab in Ovarian Cancer
18 60 Biggest Movers From Yesterday
19 Top GI Oncologists Share Excitement on 16th Annual ISGIO Conference
20 Fam-trastuzumab deruxtecan-nxki improves outcomes in gastric cancer subset
21 Talking HER2-Targeted Therapy With Dr. Ajani
22 Medicxi's David Grainger and Francesco De Rubertis pump €200M into six companies and what they say is a first-of-its kind fund
23 Expert Discusses Individualized Care for GI Cancers
24 Nivolumab Plus Regorafenib Regimen Active in Gastrointestinal Cancers
25 Aspirin linked to reduction in risk of several cancers of the digestive tract
26 Dr. Smaglo on the Role of Immunotherapy in Advanced Gastric Cancer
27 Van Morris, MD, Discusses Novel Therapies for Patients with Colorectal and Anal Cancer
28 Oncologie, Inc. Announces Collaboration with Moffitt Cancer Center to Advance the Development of Precision Medicine for the Treatment of Gastric and Gastrointestinal Cancers
29 A press officer departs Anthony Fauci's NIAID after his unmasking as a hard-right Covid misinformation troll
30 Dr. Kaseb on Research With Targeted Therapy in HCC
31 Pant Provides Insight on Key ASCO 2020 Data in Gastrointestinal Malignancies
32 Dr. Kim on Efficacy and Next Steps With Regorafenib/Nivolumab Combo in CRC
33 Dr. Pothuri on Patient-Reported Outcomes With Niraparib in Advanced Ovarian Cancer
34 Liposomal Irinotecan Regimen Pushes Toward Frontline Treatment in Metastatic Pancreatic Cancer
35 Kiniksa Announces Upcoming Rilonacept Analyst Day
36 Analyzing the ESPAC-5F Trial in Borderline Resectable Pancreatic Cancer
37 Expanding Options for Relapsed/Refractory Gastrointestinal Stromal Tumors
38 Anti-HER2 Agents Explored Further in Gastric, Colorectal, and NSCLC Settings
39 Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective
40 Rivoceranib fails to significantly improve OS in advanced gastric cancer
41 Targeted treatments extend survival in pancreatic cancer
42 OncLive and The Ruesch Center for the Cure of Gastrointestinal Cancers Names the 2020 Honorees of the Luminary Awards in GI Cancers
43 FDA grants orphan drug designation to OBI-999 for gastric cancer
44 Experts Highlight Promise of Trastuzumab Deruxtecan in Gastric/GEJ Cancers
45 Watch-and-wait strategy may be appropriate for certain patients with rectal cancer
46 Exploring Regorafenib and Nivolumab as Treatment for Colorectal Cancer
47 Tabernero Finds New Paths in Gastrointestinal Treatment Landscape
48 Gum disease linked to higher risk for gastric, esophageal cancers
49 Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
50 Oncology | Duncan Cancer Center | Baylor Medicine
51 Drug Duo Is Promising in Older Patients With Advanced HCC
52 Moffitt Cancer Center names president and CEO
53 Emotional Distress During the COVID-19 Pandemic: Psycho-Oncology Perspective
54 Renowned Gastrointestinal Radiation Oncologist Hired to Lead Clinical Cancer Research at Mount Sinai
55 Karen H. Lu, MD, on Addresses Gap in Genetic Counseling for Women at Risk for Ovarian Cancer
56 City of Hope names pathology department chair, lymphoma center associate director
57 Negative screening colonoscopy linked with reduced CRC, mortality
58 Patients with Gynecologic Cancer May Not be at Increased Risk of COVID-19
59 Fox Chase Cancer Center creates department of bone marrow transplant, cellular therapies
60 An Oncology Fellowship Is a Dynamic Process
61 OncMadness: Meet the Blue Ribbon Panel
62 Real-World Data Indicate Favorable Efficacy With Nivolumab in Advanced Gastric Cancer
63 When a Cancer Patient Tests Positive for Covid-19
64 Binimetinib Combo Shows Clinical Activity in Advanced GIST
65 Sociodemographic factors may influence survival among young adults with colorectal cancer
66 Karen H. Lu, MD, on Genetic Testing From Patients' Living Rooms
67 Guillermo Garcia-Manero, MD, on Eprenetapopt-Azacytidine Combo in TP53+ MDS
68 Nurse-Led Telephone Triage Decreases Hospitalizations and Cancer Costs
69 Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials
70 Dr. Huey on Challenges Faced With Immunotherapy in HCC
71 Doctors Debate: Should the Screening Age for Colonoscopy Be Reduced in Average-Risk Patients?
72 Christopher R. Flowers, MD, on Disparities in Lymphoma and Myeloma
73 Ramucirumab Maintains Activity, Tolerability After Non-Sorafenib Frontline Therapy in HCC
74 Triplet and Doublet Regimens Outperform Standard of Care on Survival, QoL in BRAF+ CRC
75 Cathy Eng named co-leader of GI cancer program at Vanderbilt
76 Addition of cetuximab to chemotherapy shortens OS in advanced colorectal cancer subset
77 ONCOLOGY® Welcomes Six Tumor Chairs to Editorial Advisory Board
78 Surgeon to lead breast oncology program at Jefferson Health
79 Oncology® Welcomes Julie M. Vose, M.D., MBA, and Howard S. Hochster, M.D., FACP, as Co-Editors in Chief
80 Why Alicia Keys Embraces Her Inner Underdog: 'I Was Supposed to End Up a Prostitute or Addicted to Drugs'
81 Experts Reflect on the Most Impactful FDA Moves of 2019
82 2020 ASCO Recap: Experts Review Most Impactful Oncology/Hematology Data
83 COVID-19 Infects GI Tract, a Possible Route of Viral Transmission
84 Atezolizumab/Bevacizumab Shows Comparable Activity in Older Patients With Advanced HCC
85 Cleveland Clinic appoints department chair
86 Spartalizumab Shows Promise in Patients With Advanced/Metastatic Anaplastic Thyroid Cancer
87 H. pylori treatment reduces gastric cancer risk for certain individuals with family history of disease
88 Breath test helps identify colorectal cancer
89 Should Routine Colon Cancer Screening Start at 45, Not 50?
90 Colon Cancer Symptoms That Are Easily Overlooked
91 Proton therapy reduces toxicity risk vs. IMRT in locally advanced esophageal cancer
92 Cancer researcher becomes The US Oncology Network's chief scientific officer
93 Dabrafenib-trametinib combination active in BRAF -mutated biliary tract cancer
94 Decisional Capacity Determination in Patients With Cancer
95 Evolutions in Hepatocellular Carcinoma in the Era of COVID-19
96 Oral Microbiota as Promising Diagnostic Biomarkers for Gastrointestina | OTT
97 Dr. Ahmed on Key Strategies for Managing Breast Cancer Brain Metastases
98 Evolving Treatment Paradigms for Metastatic Liver Cancer
99 Obama says democracy at risk if Republicans try to fill Ginsburg Supreme Court vacancy before election
100 Lerman Named AACI President-Elect; Three Other Cancer Center Leaders Added to Board of Directors